PepGen Quote - PEPG

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

4.51

Bid

4.19

Offer

4.71

Volume

0.00 Day's Range 0.00

2.90 52 Week Range 19.298

Market Cap

147.007M

Previous Close

4.51

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

143,330

Shares Outstanding

32,595,737

Dividend Yield

PE Ratio

-1.87

Earnings Per Share (EPS)

-2.41

Revenue

Net Profit

-78.63M

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

pepgen.com

Headquarters

Wilmington, Delaware, USA

Founded

PepGen Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PEPG. The last closing price for PepGen was US$4.51. Over the last year, PepGen shares have traded in a share price range of US$ 2.90 to US$ 19.298.

PepGen currently has 32,595,737 shares in issue. The market capitalisation of PepGen is US$147.01 million. PepGen has a price to earnings ratio (PE ratio) of -1.87.

Form 8-K - Current report

PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular Dystrophy

-Company continues to advance PGN-EDO51 in CONNECT1-EDO51, with the 10 mg/kg cohort now fully enrolled- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next...

PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.9127	-16.8310988991	5.4227	5.72	2.9	460713	4.7138528	CS
4	0.4987	12.4323785307	4.0113	6.85	2.9	221253	5.06499377	CS
12	-4.36	-49.1544532131	8.87	9.935	2.9	143330	5.83116421	CS
26	-12.49	-73.4705882353	17	19.298	2.9	155939	9.46590959	CS
52	-2.11	-31.8731117825	6.62	19.298	2.9	127445	10.8028681	CS
156	-11.09	-71.0897435897	15.6	20	2.9	112820	10.85310861	CS
260	-11.09	-71.0897435897	15.6	20	2.9	112820	10.85310861	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AALAmerican Airlines Group Inc	US$ 16.52 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 71.69 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.38 (0.00%)	0
AACGATA Creativity Global	US$ 0.8991 (0.00%)	0
AALAmerican Airlines Group Inc	US$ 16.52 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 71.69 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.38 (0.00%)	0
AACGATA Creativity Global	US$ 0.8991 (0.00%)	0
AALAmerican Airlines Group Inc	US$ 16.52 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 71.69 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.38 (0.00%)	0
AACGATA Creativity Global	US$ 0.8991 (0.00%)	0